07 novembre 2017 Radioterapia

Raysearch enters into the field of Boron Neutron Capture Therapy

RaySearch and Neutron Therapeutics, Inc., based in Danvers, US, have entered into an agreement regarding treatment planning for boron neutron capture therapy (BNCT), which is a unique type of radiation therapy that enables targeting of cancer at the cellular level.

BNCT uses a two-step process. First, the patient is injected with a tumor-localizing drug containing the non-radioactive isotope boron-10. In the second step, the target area is exposed to a beam of low-energy neutrons, many of which are absorbed by the boron-10. The absorption initiates a reaction in which short-range, high-energy charged particles are emitted. These particles systematically destroy the tumor cells, with minimal damage to adjacent healthy tissue.

As part of this agreement, RayStation’s functionality will be extended to support BNCT planning requirements*. BNCT will be an additional treatment modality in RayStation, alongside the existing options for photon, electron, proton, and carbon ion* therapy. Users of BNCT will have access to the full range of advanced functionality in RayStation, such as atlas-based segmentation, deformable image registration and scripting.

Neutron Therapeutics is developing a complete single-room solution for BNCT, including an accelerator-based neutron source, treatment room equipment, and a dose engine interfaced to a RayStation treatment planning system. The first installation of the system will be at Helsinki University Hospital, and the facility is scheduled to open in 2018.

Theodore Smick, CEO of Neutron Therapeutics, says: “We are glad to have RaySearch as a partner in the effort to create a comprehensive solution and make the benefits of BNCT available to the patients who need it. Clinics that want to adopt this powerful treatment technique will need high-quality, BNCT-specific treatment planning software, which RaySearch can provide.”

Johan Löf, CEO of RaySearch, says: “We are very pleased to extend RayStation’s capabilities to support BNCT and integrate with Neutron Therapeutics technology. BNCT has great potential and I’m excited to explore the clinical benefits and enable the use of this treatment technique in routine hospital workflow.”


About Neutron Therapeutics
Neutron Therapeutics is a medical equipment company that is developing a comprehensive solution for BNCT. The company was founded in 2014, with a mission to apply high-power proton accelerator technology to the challenge of a practical in-hospital neutron source. 


12/02/2018 News

TESI DI LAUREA: PLANNING AUTOMATION Algoritmo di ottimizzazione euristica per il trattamento del carcinoma della prostata con tecnica VMAT Heuristic optimization algorithm for the treatment of prostat

Tecnologie Avanzate è lieta di pubblicare la tesi di laurea dell' Ing Alessandro Alparone dal titolo "PLANNING AUTOMATION Algoritmo di ottimizzazione euristica per il trattamento del carcinoma della prostata con t [...]

02/02/2018 News

Mitchell Cancer Institute, US, selects RayStation for TomoTherapy

The University of South Alabama Mitchell Cancer Institute (MCI) in Mobile, Alabama, has selected RayStation* as its treatment planning system for the TomoTherapy ® System. The center also treats patients using a [...]

30/01/2018 Radioterapia

RayStation selected for India’s first Proton Center

Apollo Hospitals, Asia´s foremost integrated healthcare provider, as selected RayStation for a new proton therapy center in Chennai – the first such facility in India. The center will be equipped with IBA& [...]


20gen2017 | Eventi

RayCare Symposium, Roma 26 gennaio 2017

Tecnologie Avanzate è lieta di comunicare che il 26 gennaio organizza a Roma il primo RayCare Symposium, un incontro destinato a presentare in [...]

01mar2018 | Eventi


Tecnologie Avanzate sarà sponsor del congresso "THINK TANK MEETING ON RESEARCH CHALLENGES IN BREAST CANCER" che avrà uogo ad Assisi dall [...]

Video gallery